1-20 of 49
Agnes Guerci-Bresler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics, Outcomes, Tfr Rates in Young Adults with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era: A French Observational Study

Laurence Legros, Francoise Huguet, Pascale Cony-Makhoul, Irit Touitou, Franck E. Nicolini, Delphine Rea, Marc G. Berger, Madalina Uzunov, Lydia Roy, Martine Escoffre Barbe, Agnes Guerci Bresler, Gabriel Etienne, Elisabeth Daguenet, Amelie Penot, Martine Gardembas Pain, Shanti Ame, Eric Jourdan, Hyacinthe A. Johnson-Ansah, Valerie Coiteux, Antoine Machet, Eric Lippert, Anne Vekoff, Jean Michel Karsenti, Stéphane Morisset, Francois Mahon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1800.
https://doi.org/10.1182/blood-2023-173132
Published: 2023
Journal Articles

Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multicenter Clinical Trial

Félix López Cadenas, Eva Lumbreras, Teresa González, Blanca Xicoy, Joaquín Sánchez-García, Rosa Coll, Bohrane Slama, José Ángel Hernández-Rivas, Sylvain Thepot, Teresa Bernal, Agnès Guerci-Bresler, Guillermo Sanz, Joan Bargay, Maria Luz Amigo, Raquel De Paz Arias, Claude Preudhomme, Aristoteles Giagounidis, Uwe Platzbecker, Stefan Wickenhauser, Katharina S. Goetze, Ali Arar, Jesús M Hernández Rivas, Sofía M Toribio Castelló, Pierre Fenaux, Consuelo Del Cañizo, Maria Diez-Campelo
Journal: Blood
Blood (2022) 140 (Supplement 1): 1109–1111.
https://doi.org/10.1182/blood-2022-168718
Published: 2022
Journal Articles

Long-Term Evolution of Somatic Mutations in Patients with Del(5q) MDS Early Treated with Lenalidomide in the Sintra-Rev Clinical Trial: Safe and Effecitive Approach?

Sofía M Toribio Castelló, Felix Lopez-Cadenas, Claude Preudhomme, Angela Villaverde Ramiro, Laurène Fenwarth, Eva Lumbreras, Teresa González, Mónica Del Rey, Blanca Xicoy, Aline Renneville, Joaquín Sánchez-Garcia, Rosa Coll, Bohrane Slama, José Ángel Hernández-Rivas, Sylvain Thepot, Teresa Bernal, Agnès Guerci-Bresler, Katharina Götze, Jesús María Hernández-Rivas, Pierre Fenaux, Consuelo Del Cañizo, Maria Diez-Campelo
Journal: Blood
Blood (2022) 140 (Supplement 1): 9740–9743.
https://doi.org/10.1182/blood-2022-168599
Published: 2022
Journal Articles

Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group

Andreas Burchert, Susanne Saussele, Christian Michel, Stephan K Metzelder, Andreas Hochhaus, Norbert Gattermann, Martina Crysandt, Philippe Schafhausen, Matthias Bormann, Markus P. Radsak, Agnès Guerci-Bresler, Thomas Illmer, Maria E Goebeler, Peter Herhaus, Lino L. Teichmann, Georg-Nikolaus Franke, Fabian Lang, Stefan W. Krause, Robert Möhle, Martine Klausmann, Frank Stegelmann, Christoph Lutz, Gabriel Etienne, Andrea Stoltefuß, Joachim R Göthert, Thomas Ernst, Andreas Neubauer, Rüdiger Hehlmann, Behnaz Aminossadati, Michael Wittenberg, Markus Pfirrmann, Carmen Schade-Brittinger, Philipp le Coutre, Franck E. Nicolini
Journal: Blood
Blood (2022) 140 (Supplement 1): 1501–1503.
https://doi.org/10.1182/blood-2022-169324
Published: 2022
Journal Articles

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry: A Report on 197 Cases

Inga Mandac Smoljanovic, Adele Taylor, Pierre Fenaux, Agnès Guerci-Bresler, Raphael Itzykson, Argiris Symeonidis, Ioannis Kotsianidis, Moshe Mittelman, Guillermo Sanz, Dominic J. Culligan, Jaroslav Cermak, Reinhard Stauder, Eva Hellström-Lindberg, Luca Malcovati, Saskia M.C. Langemeijer, Ulrich Germing, Krzysztof Madry, Howard S. Oster, Alexandra Smith, Corine van Marrewijk, Theo M de Witte, David Bowen
Journal: Blood
Blood (2022) 140 (Supplement 1): 9802–9803.
https://doi.org/10.1182/blood-2022-167716
Published: 2022
Journal Articles

Last Interim Results of the Real-Life Study Evaluating the Efficacy and Safety of Ponatinib "Topase” in Patients with TKI-Resistant or Intolerant CML

Emilie Cayssials, Gabriel Etienne, Ali G Turhan, Philippe Rousselot, Valerie Coiteux, Marc G. Berger, Francoise Huguet, Agnes Guerci-Bresler
Journal: Blood
Blood (2022) 140 (Supplement 1): 6776–6777.
https://doi.org/10.1182/blood-2022-166111
Published: 2022
Journal Articles

Treatment Free Survival (TFS) in Patients (pts) with Chronic Myeloid Leukemia (CML) Carrying Atypical BCR-ABL1 Fusion Transcripts: The French CML Group (Fi-LMC) Experience

Hyacinthe Johnson-Ansah, Aude Charbonnier, Delphine Rea, Gabriel Etienne, Lydia Roy, Laurence Legros, Agnes Guerci Bresler, Anne Bouvier, Emilie Cayssials, Valerie Coiteux, Philippe Rousselot, Stephanie Dulucq, Sandrine Hayette, Francois-Xavier Mahon, Franck E. Nicolini
Journal: Blood
Blood (2021) 138 (Supplement 1): 3604.
https://doi.org/10.1182/blood-2021-147537
Published: 2021
Journal Articles

Management of MDS with Isolated Del(5q) Patients in the European MDS (EUMDS) Registry, a Unique Prospective Real-World Dataset

David Bowen, Adele Taylor, Pierre Fenaux, Agnes Guerci-Bresler, Raphael Itzykson, Argiris Symeonidis, Ioannis Kotsianidis, Moshe Mittelman, Guillermo Sanz, Dominic J. Culligan, Jaroslav Cermak, Reinhard Stauder, Eva Hellstrom Lindberg, Luca Malcovati, Saskia M. C. Langemeijer, Ulrich Germing, Howard S. Oster, Krzysztof Madry, Mette Skov Holm, Alexandra Smith, Corine van Marrewijk, Theo M de Witte
Journal: Blood
Blood (2021) 138 (Supplement 1): 4671.
https://doi.org/10.1182/blood-2021-150322
Published: 2021
Journal Articles

Treatment-Free Remissions in Newly Diagnosed CP CML Patients Treated with the Combination of Nilotinib + Pegylated Interferon Alpha 2a Versus Nilotinib Alone in the National Phase III Petals Trial

Franck E. Nicolini, Gabriel Etienne, Francoise Huguet, Agnès Guerci-Bresler, Aude Charbonnier, Martine Escoffre-Barbe, Viviane Dubruille, Hyacinthe Johnson-Ansah, Laurence Legros, Valerie Coiteux, Pascale Cony-Makhoul, Pascal Lenain, Lydia Roy, Philippe Rousselot, Denis Guyotat, Jean-Christophe Ianotto, Corentin Orvain, Eric Deconinck, Denis Caillot, Pascal Turlure, Stephane Courby, Philippe Quittet, Eric Hermet, Shanti Amé, Simona Lapusan, Stephane Morisset, Francois-Xavier Mahon, Delphine Rea, Stephanie Dulucq
Journal: Blood
Blood (2021) 138 (Supplement 1): 2553.
https://doi.org/10.1182/blood-2021-146412
Published: 2021
Journal Articles

Red Blood Cell Transfusion Burden in Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS): A Retrospective Multicenter Study By the Groupe Francophone Des Myélodysplasies (GFM)

Claire Jouzier, Amina Cherait, Pascale Cony-Makhoul, MD, Sylvain Thepot, MD, Thomas Cluzeau, MD PhD, Aspasia Stamatoulas Bastard, MD, Pierre Peterlin, MD, Agnes Guerci Bresler, MD, Sophie Dimicoli-Salazar, MD, Gian-Matteo Pica, MD, Stephane Cheze, MD, Clémence Santana, MD, Fatiha Chermat, Pierre Fenaux, MD PhD, Sophie Park, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-138722
Published: 2020
Journal Articles

Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial

Félix López Cadenas, MD, Eva Lumbreras, Blanca Xicoy, MD, Joaquín Sánchez, MD, Rosa Coll, MD, Bohrane Slama, MD, Jose Angel Hernandez-Rivas, MD PhD, Sylvain Thepot, MD, Teresa Bernal, MD PhD, Beatriz Arrizabalaga, MD PhD, Agnès Guerci-Bresler, MD PhD, Guillermo F Sanz, MD PhD, Joan Bargay, MD, Maria Luz Amigo, MD, Raquel de Paz, MD, Benet Nomdedeu, MD, Aristoteles Giagounidis, Uwe Platzbecker, Stefan Wickenhauser, Katharina S. Götze, Ali Arar, Jesus María Hernández Rivas, MD PhD, Pierre Fenaux, MD PhD, Consuelo Del Cañizo, MDPhD, Maria Diez-Campelo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-140339
Published: 2020
Journal Articles

Prospective Evaluation of ABL Kinase Domain Mutational Analysis By Next-Generation-Sequencing in Newly Diagnosed CP CML Patients Undergoing First-Line Treatment with Nilotinib Alone or Nilotinib + Pegylated Interferon-α2a in a Prospective Phase III Trial

Hugues de Lavallade, MD PhD, Sophie Jackson, BSc, Aytug Kizilors, PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnes Guerci-Bresler, MD PhD, Delphine Rea, MD, Claudine Chollet, MSc, Stephane Morisset, BioStat, Fanny Robbesyn, BSc, Francois-Xavier Mahon, MD PhD, Stephanie Dulucq, PharmD, PhD, Franck E Nicolini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 664.
https://doi.org/10.1182/blood-2019-125108
Published: 2019
Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Franck E Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnès Guerci-Bresler, MD PhD, Aude Charbonnier, MD PhD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD PhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, MD PhD, Denis Guyotat, MD PhD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Eric Deconinck, MD PhD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Alexandre Deloire, CRA, Stephane Morisset, BioStat, Madeleine Etienne, CRA, Delphine Rea, MD, Stephanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 494.
https://doi.org/10.1182/blood-2019-123674
Published: 2019
Journal Articles

Characteristics and Outcome of Older Patients with Acute Promyelocytic Leukemia Front-Line Treated with or without Arsenic Trioxide — an International Collaborative Study

Sabine Kayser, MD, Ramy Rahmé, David Martínez-Cuadron, MD, Gabriel Ghiaur, MD PhD, Xavier Thomas, MD, Marta Sobas, MD, Agnes Guerci Bresler, Salut Brunet, MD PhD, Arnaud Pigneux, MD PhD, Cristina Gil, MD, Emmanuel Raffoux, Mar Tormo, MD PhD, Norbert Vey, MD PhD, Javier de la Serna, MD, Olga Salamero, MD, Eva Lengfelder, MD, Mark J. Levis, MD, Pierre Fenaux, MD PhD, Miguel A. Sanz, MD, Richard F. Schlenk, MD, Uwe Platzbecker, Lionel Ades, MD PhD, Pau Montesinos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 80.
https://doi.org/10.1182/blood-2018-99-111768
Published: 2018
Journal Articles

Excess Mortality in Low-Risk MDS Can be Explained By MDS and AML Related Causes of Death

Krzysztof Madry, Ge Yu, MSc., Karol Lis, MD, Pierre Fenaux, MD PhD, David Bowen, MD PhD, Argiris Symeonidis, MD PhD, Moshe Mittelman, MD, Reinhard Stauder, MD MSc, Jaroslav Cermak, MD PhD, Guillermo Sanz, Eva Hellström-Lindberg, MD PhD, Luca Malcovati, MD, Saskia Langemeijer, MD PhD, Ulrich Germing, MD, Mette Skov Holm, MD PhD, Agnès Guerci-Bresler, MD, Dominic Culligan, MD, Laurence Sanhes, MD, Juliet Mills, MD, Ioannis Kotsianidis, MD PhD, Corine van Marrewijk, PhD, Simon Crouch, PhD BA, MA, MSc, Theo M de Witte, MD, Alexandra Smith, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4385.
https://doi.org/10.1182/blood-2018-99-115928
Published: 2018
Journal Articles

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Howard S. Oster, MD PhD, Simon Crouch, MSc, PhD, Alexandra Smith, PhD, Ge Yu, MSc, Bander Abu Shrkihe, MD, Shoham Baruch, Albert Kolomansky, MD, Jonathan Ben-Ezra, MD, Shachar Naor, MD, Pierre Fenaux, MD PhD, Argiris Symeonidis, MD PhD, Reinhard Stauder, MD MSc, Jaroslav Cermak, MD PhD, Guillermo Sanz, Eva Hellström-Lindberg, MD PhD, Luca Malcovati, MD, Saskia Langemeijer, MD PhD, Ulrich Germing, MD, Mette Skov Holm, MD PhD, Krzysztof Madry, Agnes Guerci-Bresler, MD, Dominic Culligan, MD, Laurence Sanhes, MD, Juliet Mills, MD, Ioannis Kotsianidis, PhD, Corine van Marrewijk, PhD, David Bowen, MD PhD, Theo de Witte, MD PhD, Moshe Mittelman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4357.
https://doi.org/10.1182/blood-2018-99-111838
Published: 2018
Journal Articles

Using Healthcare Claims Data to Analyze the Prevalence of Chronic Myeloid Leukemia in France: A Nationwide Population-Based Study

Stephanie Foulon, MD, Pascale Cony-Makhoul, MD PhD, Agnes Guerci-Bresler, MD PhD, Marc Delord, PhD, Eric Solary, MD PhD, Alain Monnereau, MD PhD, Julia Bonastre, PhD, Pascale Tubert Bitter, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3015.
https://doi.org/10.1182/blood-2018-99-111489
Published: 2018
Journal Articles

Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

Reinhard Stauder, MD MSc, Ge Yu, MSc., Karin A Koinig, PhD, Dominic Culligan, MD, Pierre Fenaux, MD PhD, Jaroslav Cermak, MD PhD, Argiris Symeonidis, MD PhD, Teresa Bernal, MD, Eva Hellström-Lindberg, MD PhD, Moshe Mittelman, MD, Saskia Langemeijer, MD PhD, Mette Skov Holm, MD PhD, Juliet Mills, MD, Agnès Guerci-Bresler, MD, Corine van Marrewijk, PhD, Hege Garelius, MD, Fabio Efficace, PhD, Alexandra Smith, PhD, David Bowen, MD PhD, Theo M de Witte, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3097.
https://doi.org/10.1182/blood-2018-99-112508
Published: 2018
Journal Articles

The Impact of Diabetes Mellitus As Comorbid Condition, in Patients with Lower-Risk Myelodysplastic Syndromes (MDS)— a Study of the European Leukemianet-Based MDS (EUMDS) Registry

Argiris Symeonidis, MD PhD, Ge Yu, PhD, Alexandra Smith, PhD, Pierre Fenaux, MD PhD, Moshe Mittelman, MD, Reinhard Stauder, MD, Guillermo Sanz, MD, Jaroslav Cermak, MD PhD, Eva Hellstrom-Lindberg, MD PhD, Luca Malcovati, MD, Saskia Langemeijer, MD PhD, Ulrich Germing, MD, Krzysztof Madry, MD PhD, Mette Skov Holm, MD PhD, Aurelia Tatic, MD, Antonio Medina de Almeida, MD PhD, Aleksandar Savic, MD PhD, Njetocka Gredelj Simec, Agnes Guerci-Bresler, Jackie Droste, PhD, T. M. M de Witte, MD PhD, David T. Bowen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4264.
https://doi.org/10.1182/blood.V130.Suppl_1.4264.4264
Published: 2017
Journal Articles

An Integrated Analysis of Darbepoetin Alfa (DAR) in the Treatment of Anemia in Patients with Low- or Intermediate-1 (int-1) Risk Myelodysplastic Syndrome (MDS)

Uwe Platzbecker, MD, Argiris Symeonidis, MD PhD, Jeroen Simon Goede, Agnes Guerci-Bresler, Michel Delforge, MDPhD, Esther Natalie Oliva, MD, Jiri Mayer, Prof, MD SCs, Sejal Badre, Bhakti Mehta, Cisio De Oliveira Brandao
Journal: Blood
Blood (2017) 130 (Supplement 1): 4271.
https://doi.org/10.1182/blood.V130.Suppl_1.4271.4271
Published: 2017